Christopher Raymond
Stock Analyst at Raymond James
(3.40)
# 2,431
Out of 4,556 analysts
867
Total ratings
45.4%
Success rate
2.5%
Average return
Main Sectors:
Stocks Rated by Christopher Raymond
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYRA Tyra Biosciences | Maintained: Buy | n/a | $30.59 | - | 8 | Jul 17, 2026 | |
| CLYM Climb Bio | Maintained: Buy | n/a | $12.58 | - | 3 | Jun 24, 2026 | |
| BHVN Biohaven | Maintained: Buy | n/a | $14.75 | - | 22 | Jun 24, 2026 | |
| AKTS Aktis Oncology | Initiated Coverage: Buy | $40 | $24.81 | +61.23% | 1 | Jun 16, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | n/a | $58.40 | - | 86 | May 22, 2026 | |
| ALMS Alumis | Maintained: Buy | $46 | $28.81 | +59.67% | 2 | Mar 27, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Buy | $723 → $870 | $651.18 | +33.60% | 114 | Jan 30, 2026 | |
| COGT Cogent Biosciences | Maintained: Buy | $60 | $39.54 | +51.75% | 20 | Jan 26, 2026 | |
| LXEO Lexeo Therapeutics | Maintained: Buy | $25 | $4.87 | +413.35% | 2 | Jan 13, 2026 | |
| ARDX Ardelyx | Maintained: Buy | $14 → $19 | $5.08 | +274.02% | 41 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $47 | $6.48 | +625.31% | 1 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $5.66 | +129.68% | 6 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $142 → $123 | $112.48 | +9.35% | 5 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 → $29 | $12.16 | +138.49% | 11 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $366.05 | - | 78 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $4.07 | +465.11% | 14 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $533 → $401 | $472.57 | -15.14% | 26 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $5.62 | n/a | 6 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 | $27.65 | n/a | 58 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $4 | $15.08 | n/a | 6 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $129.73 | n/a | 5 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $220 → $227 | $253.30 | n/a | 84 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $75 | $7.18 | n/a | 21 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $307 → $315 | $197.74 | n/a | 91 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $9.51 | n/a | 19 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $56 | $36.05 | n/a | 11 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $0.001 | n/a | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 → $8 | $2.02 | n/a | 24 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 | $54.01 | n/a | 1 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $1.26 | n/a | 22 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $600 | $851.72 | n/a | 1 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $22 | $56.26 | n/a | 1 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $2.06 | n/a | 1 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $28 | $0.7444 | n/a | 5 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $36.65 | n/a | 1 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $5.94 | n/a | 6 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $75 → $30 | $8.10 | n/a | 5 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $6 | $1.06 | n/a | 20 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $37.80 | n/a | 12 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $6.43 | n/a | 4 | Mar 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $30.15 | n/a | 1 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.08 | n/a | 6 | Aug 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $42 → $101 | - | n/a | 2 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.001 | n/a | 6 | Mar 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $3 → $6 | $3.02 | n/a | 3 | Feb 29, 2012 |
Tyra Biosciences
Jul 17, 2026
Maintained: Buy
Price Target: n/a
Current: $30.59
Upside: -
Climb Bio
Jun 24, 2026
Maintained: Buy
Price Target: n/a
Current: $12.58
Upside: -
Biohaven
Jun 24, 2026
Maintained: Buy
Price Target: n/a
Current: $14.75
Upside: -
Aktis Oncology
Jun 16, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $24.81
Upside: +61.23%
BioMarin Pharmaceutical
May 22, 2026
Maintained: Buy
Price Target: n/a
Current: $58.40
Upside: -
Alumis
Mar 27, 2026
Maintained: Buy
Price Target: $46
Current: $28.81
Upside: +59.67%
Regeneron Pharmaceuticals
Jan 30, 2026
Maintained: Buy
Price Target: $723 → $870
Current: $651.18
Upside: +33.60%
Cogent Biosciences
Jan 26, 2026
Maintained: Buy
Price Target: $60
Current: $39.54
Upside: +51.75%
Lexeo Therapeutics
Jan 13, 2026
Maintained: Buy
Price Target: $25
Current: $4.87
Upside: +413.35%
Ardelyx
Jan 8, 2026
Maintained: Buy
Price Target: $14 → $19
Current: $5.08
Upside: +274.02%
Dec 2, 2025
Initiated Coverage: Buy
Price Target: $47
Current: $6.48
Upside: +625.31%
Nov 25, 2025
Maintained: Buy
Price Target: $13
Current: $5.66
Upside: +129.68%
Nov 14, 2025
Maintained: Buy
Price Target: $142 → $123
Current: $112.48
Upside: +9.35%
Oct 20, 2025
Initiated Coverage: Buy
Price Target: $26 → $29
Current: $12.16
Upside: +138.49%
Oct 10, 2025
Maintained: Hold
Price Target: n/a
Current: $366.05
Upside: -
Sep 16, 2025
Maintained: Buy
Price Target: $23
Current: $4.07
Upside: +465.11%
Sep 2, 2025
Initiated Coverage: Hold
Price Target: $533 → $401
Current: $472.57
Upside: -15.14%
Feb 18, 2025
Maintained: Buy
Price Target: $13
Current: $5.62
Upside: n/a
Feb 14, 2025
Maintained: Buy
Price Target: $140
Current: $27.65
Upside: n/a
Feb 11, 2025
Downgraded: Hold
Price Target: $20 → $4
Current: $15.08
Upside: n/a
Feb 10, 2025
Maintained: Buy
Price Target: $42
Current: $129.73
Upside: n/a
Jan 27, 2025
Rated: Buy
Price Target: $220 → $227
Current: $253.30
Upside: n/a
Jan 27, 2025
Rated: Buy
Price Target: $75
Current: $7.18
Upside: n/a
Oct 30, 2024
Maintained: Buy
Price Target: $307 → $315
Current: $197.74
Upside: n/a
Oct 23, 2024
Rated: Buy
Price Target: $20
Current: $9.51
Upside: n/a
Oct 23, 2024
Rated: Buy
Price Target: $56
Current: $36.05
Upside: n/a
Sep 16, 2024
Rated: Buy
Price Target: $10
Current: $0.001
Upside: n/a
Aug 9, 2024
Rated: Buy
Price Target: $21 → $8
Current: $2.02
Upside: n/a
Oct 25, 2023
Maintained: Buy
Price Target: $58
Current: $54.01
Upside: n/a
Oct 25, 2023
Maintained: Buy
Price Target: $4
Current: $1.26
Upside: n/a
Oct 25, 2023
Maintained: Buy
Price Target: $600
Current: $851.72
Upside: n/a
Jul 24, 2023
Rated: Hold
Price Target: $22
Current: $56.26
Upside: n/a
Apr 25, 2023
Maintained: Buy
Price Target: $14
Current: $2.06
Upside: n/a
Nov 22, 2022
Maintained: Hold
Price Target: $28
Current: $0.7444
Upside: n/a
Jul 25, 2022
Initiated Coverage: Buy
Price Target: $28
Current: $36.65
Upside: n/a
May 23, 2022
Maintained: Buy
Price Target: $3
Current: $5.94
Upside: n/a
May 18, 2022
Maintained: Hold
Price Target: $75 → $30
Current: $8.10
Upside: n/a
May 11, 2021
Maintained: Hold
Price Target: $7 → $6
Current: $1.06
Upside: n/a
Apr 13, 2021
Maintained: Buy
Price Target: $8
Current: $37.80
Upside: n/a
Mar 27, 2020
Maintained: Buy
Price Target: n/a
Current: $6.43
Upside: n/a
Apr 18, 2019
Maintained: Hold
Price Target: n/a
Current: $30.15
Upside: n/a
Aug 7, 2017
Rated: Hold
Price Target: n/a
Current: $4.08
Upside: n/a
Mar 31, 2015
Downgraded: Hold
Price Target: $42 → $101
Current: -
Upside: n/a
Mar 19, 2013
Maintained: Hold
Price Target: n/a
Current: $0.001
Upside: n/a
Feb 29, 2012
Upgraded: Buy
Price Target: $3 → $6
Current: $3.02
Upside: n/a